Evidence map›Paper›PMID 25716197›Full record

ReviewAlcohol (Fayetteville, N.Y.)2015

Ethanol and corticotropin releasing factor receptor modulation of central amygdala neurocircuitry: An update and future directions.

Yuval Silberman, Danny G Winder

Abstract readReview
In one paragraph

Review in Alcohol (Fayetteville, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yuval SilbermanDepartment of Molecular Physiology and Biophysics, Vanderbilt Brain Institute, Neuroscience Program in Substance Abuse, Vanderbilt University Medical Center, 2200 Pierce Ave., Nashville, TN 37232, USA. Electronic address: yuval.silberman@vanderbilt.edu.
Danny G WinderDepartment of Molecular Physiology and Biophysics, Vanderbilt Brain Institute, Neuroscience Program in Substance Abuse, Vanderbilt University Medical Center, 2200 Pierce Ave., Nashville, TN 37232, USA.
Vanderbilt University Medical Center · US

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Alcohol action on extended amygdala glutamate synapsesR37AA019455 · NIAAA · VANDERBILT UNIVERSITY · PI WINDER, DANNY G. · 2015 to 2024
$3.9M
Periadolescent Noradrenergic Regulation in the BNSTR01DA019112 · NIDA · VANDERBILT UNIVERSITY · PI WINDER, DANNY G. · 2004 to 2014
$3.3M
Alcohol action on extended amygdala glutamate synapsesR01AA019455 · NIAAA · VANDERBILT UNIVERSITY · PI WINDER, DANNY G. · 2010 to 2014
$1.8M
Engagement of novel noradrenergic and CRF circuit interactions by chronic alcoholR00AA022937 · NIAAA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SILBERMAN, YUVAL · 2016 to 2018
$708k
Alcoholism and Stress: A Framework for Future Treatment StrategiesR13AA017581 · NIAAA · SCRIPPS RESEARCH INSTITUTE, THE · PI ROBERTO, MARISA · 2008 to 2022
$285k
Engagement of novel noradrenergic and CRF circuit interactions by chronic alcoholK99AA022937 · NIAAA · VANDERBILT UNIVERSITY · PI SILBERMAN, YUVAL · 2014 to 2015
$278k
CRF regulation of BNST target control in alcohol withdrawalF32AA020140 · NIAAA · VANDERBILT UNIVERSITY · PI SILBERMAN, YUVAL · 2010 to 2012
$153k
NIAAA NIH HHS AA017581NIAAA NIH HHS AA19455NIAAA NIH HHS AA20140NIAAA NIH HHS AA22937NIAAA NIH HHS F32 AA020140NIAAA NIH HHS K99 AA022937NIAAA NIH HHS R00 AA022937NIAAA NIH HHS R01 AA019455NIAAA NIH HHS R13 AA017581NIAAA NIH HHS R37 AA019455NICHD NIH HHS U54 HD083211NIDA NIH HHS DA 19112NIDA NIH HHS R01 DA019112
6 · The paper itself

Abstract

The central amygdala is a critical brain region for many aspects of alcohol dependence. Much of the work examining the mechanisms by which the central amygdala mediates the development of alcohol dependence has focused on the interaction of acute and chronic ethanol with central amygdala corticotropin releasing factor signaling. This work has led to a great deal of success in furthering the general understanding of central amygdala neurocircuitry and its role in alcohol dependence. Much of this work has primarily focused on the hypothesis that ethanol utilizes endogenous corticotropin releasing factor signaling to upregulate inhibitory GABAergic transmission in the central amygdala. Work that is more recent suggests that corticotropin releasing factor also plays an important role in mediating anxiety-like behaviors via the enhancement of central amygdala glutamatergic transmission, implying that ethanol/corticotropin releasing factor interactions may modulate excitatory neurotransmission in this brain region. In addition, a number of studies utilizing optogenetic strategies or transgenic mouse lines have begun to examine specific central amygdala neurocircuit dynamics and neuronal subpopulations to better understand overall central amygdala neurocircuitry and the role of neuronal subtypes in mediating anxiety-like behaviors. This review will provide a brief update on this literature and describe some potential future directions that may be important for the development of better treatments for alcohol addiction.

Indexed as

AmygdalaAnimalsCentral Nervous System DepressantsCorticotropin-Releasing HormoneEthanolgamma-Aminobutyric AcidGlutamic AcidMiceMice, TransgenicNeuronsReceptors, Corticotropin-Releasing HormoneSynaptic TransmissionCentral Nervous System DepressantsCorticotropin-Releasing HormoneEthanolgamma-Aminobutyric AcidGlutamic AcidReceptors, Corticotropin-Releasing HormoneCentral amygdalaCorticotropin releasing factorSynaptic transmissionTransgenic mouse lines

Identifiers

PMID25716197
PMCPMC4414799
OpenAlexW2096167220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.